Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis

BreAnna Kinghorn1,2, Margaret Rosenfeld1,2, Erin Sullivan2

  • 1Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.

Insights

Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) lung function are similar in childhood, contrary to prior beliefs. Children with PCD, especially those with inner dynein arm/microtubular defects, face significant lung function decline, necessitating new treatments.

Area of Science:

  • Respiratory Medicine
  • Genetics
  • Pediatrics

Background:

  • Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are genetic disorders affecting mucociliary clearance and leading to progressive lung disease.
  • PCD is often perceived as less severe than CF in childhood, but evidence is limited.
  • Specific genetic variants in PCD, such as those in CCDC39 and CCDC40 causing inner dynein arm/microtubular defects (IDA/MTD), are linked to more severe disease presentations.

Purpose of the Study:

  • To compare longitudinal health outcomes between children diagnosed with PCD and CF.
  • To investigate if children with PCD and IDA/MTD defects exhibit poorer lung function but better nutritional status compared to CF patients with genotypes associated with pancreatic insufficiency.

Main Methods:

  • A prospective, multicenter observational study enrolled children with PCD.
  • PCD patients were matched with CF patients from the Cystic Fibrosis Foundation Patient Registry based on demographics and study visit year.
  • Longitudinal outcomes up to age 17 were analyzed using mixed-effects models, comparing disease groups and severity subclasses (PCD-IDA/MTD vs. other PCD; CF-minimal vs. residual function).

Main Results:

  • The study included 136 children with PCD (40 IDA/MTD) and 476 with CF (446 minimal function).
  • PCD patients showed similar or lower lung function (forced expiratory volume in 1 second % predicted) compared to CF patients before age 14.
  • Children with PCD-IDA/MTD had significantly lower lung function by age 10 and 14 compared to CF patients with minimal function genotypes, with similar body mass index.
  • Prevalence of Pseudomonas aeruginosa infection was higher in CF (67%) than PCD (27%), with no difference between PCD subgroups.

Conclusions:

  • Contrary to common assumptions, children with PCD do not necessarily have milder lung disease than those with CF during childhood.
  • PCD patients with IDA/MTD defects experience substantial lung function deficits, comparable to or worse than CF patients.
  • There is an urgent need for updated clinical guidelines and novel therapeutic strategies to improve outcomes for children with PCD.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
144
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
194
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K